Showing results (51-60 of 264) with videos related to
Sort By:
Pageof 27
Alzheimer Disease and Associated Disorders|December 1, 2006
ADCS Prevention Instrument Project: assessment of instrumental activities of daily living for community-dwelling elderly individuals in dementia prevention clinical trialsDouglas Galasko, David A Bennett, Mary Sano, et al.Journal of Alzheimer'S Disease : JAD|April 30, 2016
Attitudes and Perceptions of Research in Aging and Dementia in an Urban Minority PopulationJudith Neugroschl, Margaret Sewell, Angelica De La Fuente, et al.Archives of Neurology|February 13, 2003
Estrogen levels do not correlate with improvement in cognitionLeon J Thal, Ronald G Thomas, Ruth Mulnard, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|July 15, 2009
Undertreatment of patients with Alzheimer's disease in an elderly United States populationMary Sano, Joan Amatniek, Morgan Feely, et al.Journal of Geriatric Psychiatry and Neurology|August 11, 2021
Evaluating the Beijing Version of Montreal Cognitive Assessment for Identification of Cognitive Impairment in Monolingual Chinese American Older AdultsYue Hong, Xiaoyi Zeng, Carolyn W Zhu, et al.Neurobiology of Aging|September 23, 2008
Cardiovascular risk and memory in non-demented elderly womenSophia Wang, Diane Jacobs, Howard Andrews, et al.Dementia and Geriatric Cognitive Disorders|March 19, 2009
The neuropsychological performance of nondemented Puerto Rican nonagenariansJosé R Carrión-Baralt, Josefina Meléndez-Cabrero, Michal Schnaider Beeri, et al.Nephron. Clinical Practice|July 8, 2010
Cognitive profile of chronic kidney disease and hemodialysis patients without dementiaJames B Post, Adejoke B Jegede, Kel Morin, et al.The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 16, 2005
Relationship of neuropsychological performance to functional status in nursing home residents and community-dwelling older adultsMichael A Rapp, Michal Schnaider Beeri, James Schmeidler, et al.Alzheimer'S & Dementia (New York, N. Y.)|November 28, 2018
A randomized, double-blind, placebo-controlled trial of resveratrol with glucose and malate (RGM) to slow the progression of Alzheimer's disease: A pilot studyCarolyn W Zhu, Hillel Grossman, Judith Neugroschl, et al.Pageof 27